Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy

Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy

Diagnostics: Liquid biopsy detects recurrence but lacks sensitivity A blood test can detect disease recurrence among women with triple-negative breast cancer (TNBC), but lacks sensitivity for distant relapse. A team led by Milan Radovich from Indiana University School of Medicine in Indianapolis, US...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yu-Hsiang Chen, Bradley A. Hancock, Jeffrey P. Solzak, Dumitru Brinza, Charles Scafe, Kathy D. Miller, Milan Radovich
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/644623fb59ef4bd68fdc77949dcce07a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares